Arvind Kush - 17 Nov 2023 Form 4 Insider Report for RayzeBio, Inc. (RYZB)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RYZB	Stock Option (right to buy)	Award	$0	+164,000		$0.000000	164,000	17 Nov 2023	Common Stock	164,000	$22.72	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option vest in a series of 48 successive equal monthly installments over the four-year period measured from the date of grant.